PTEN and ductal breast carcinoma in situ: This pooled analysis verified that PTEN loss (p = 0.012), ERG positivity (p = 0.022), and intraductal carcinoma (IDC) (p = 0.001) were associated with a decreased likelihood of pathologic response [26].